Biotechnology | Diagnostics | NIH | Oncology | Organoids
Scientists unveil more than 600 new tissue models of human cancer
On Aug. 5, 2026, an international team led by researchers at MIT’s Koch Institute, the Broad Institute, the…
-
-
Family History Increases Cancer Risk in BRCA-Tested Patients
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
-
Biotechnology | Imaging | Medical Device | Neurology | Non-Profit Research | Oncology | Therapeutics
UVA Radiology Professors Develop New Focused Ultrasound Approach for Brain Tumors
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
-
patient receives pioneering lung cancer vaccine in World First
On Jul. 30, 2026, researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC)…
-
Biotechnology | Diagnostics | FDA | Oncology
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
On Jul. 28, 2026, The U.S. Food and Drug Administration (FDA) announced it had approved SimpleScreen™ CRC, a…
-
Tempus to Acquire Personalis for $1.5 Billion
On Jul. 20, 2026, Tempus AI, a technology company leading the adoption of AI to advance precision medicine…
-
FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
-
Researchers discover new form of hereditary prostate cancer
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
-
Agriculture | Biotechnology | Environmental | EPA | FDA | Forestry | Genomics | Implants | Infectious Disease | Marine Science | Medical Device | Oncology | Organ Transplant | Organoids | Pharmaceutical | Quantum | Robotics | Software | Stem Cell | U.S. Congress | Vaccine | Veterinary | Women's Health
New PhD Admissions Data Show Threat to U.S. STEM Workforce, Breakthroughs and Innovations
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
-
Biotechnology | Disease | Neurology | Oncology | Rare Disease | Stem Cell
New CRISPR Method Makes It Possible to Control Protein Production in Cells
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
-
Immunotherapy shows promise in treating deadly brain tumours
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic debuts AI-driven pharma R&D tool, Claude Science
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
-
EU Approves first tumour agnostic HER2-directed therapy for Breast Cancer
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
-
China’s first AI-powered cancer vaccine production line set to launch in Beijing
On Jun. 29, 2026, China announced it has broken ground on what developers say is the country’s first…
-
Self-propelled actin filaments: Novel structures driving spontaneous cell morphogenesis
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
-
Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
On Jun. 24, 2026, Antares Therapeutics announce it has entered a collaboration with Novartis that could be worth…
-
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
-
Nanoparticles sneak antibodies into cells to inhibit cancer, inflammation
On Jun. 23. 2026, scientists at Cornell University announce discovering a delivery system that uses lipid nanoparticles to…
-
Contagious Cancer Likely Crossed an Ocean, Triggering Severe Outbreak in Pacific Northwest Clams
On Jun. 23, 2026 – researchers from the Pacific Northwest Research Institute in Seattle announced they have identified…
-
Cancer-on-a-chip pioneer Chen Weiqiang returns to China from New York University
On Jun. 21, 2026, Chen Weiqiang, formerly a tenured professor of mechanical and biomedical engineering at New York…
-
USC Stem Cell-led team creates a renewable cell source for cancer immunotherapy and beyond
On Jun. 19, 2026, University of Southern California (USC) scientists report in a paper published in Cell, a…
-
GSK enters agreement to acquire Nuvalent for $10.6 Billion
On Jun. 9, 2026, GSK announced that it has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage…
-
Johnson & Johnson to Acquire Firefly Bio for $1 Billion in Cash to Expand Oncology Pipeline
On Jun. 8, 2026, Johnson & Johnson announced it has entered into a definitive agreement to acquire Firefly…
-
Pfizer and China’s Innovent Biologics Enter Global Strategic Collaboration worth $9.85 billion to Accelerate Development of Oncology Medicines
On May 28, 2026, Pfizer and Innovent Biologics announced the companies have entered into a strategic global licensing…
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus
On May 22, 2026, Gilead Sciences announced announced that the U.S. Food and Drug Administration (FDA) has granted…
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
-
Bristol Myers Squibb and Hengrui Pharma Announce Strategic Agreements to Advance Innovative Medicines in Deal Worth $15.2 billion
On May 12, 2026, Bristol Myers Squibb and Hengrui Pharma announced the companies have entered into global strategic…
-
Thousands of previously unknown proteins discovered
On May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research…
-
Study Reports unprecedented view of the immune system’s killer cells
On May 4, 2026, a study conducted by the University of Geneva and the Lausanne University Hospital (CHUV)…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Neurology | Non-Profit Research | Oncology | Therapeutics
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
